Acitretin (Soriatane) may improve outcomes for cancer patients with multikinase inhibitor (MKI)-mediated hand-foot skin reaction (HFSR), according to a small retrospective study. Of eight MKI users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback